MEET US AT BOOTH #714 TO DISCUSS CLIA-WAIVED POINT OF CARE AND PGX SOLUTIONS FOR YOUR CLINICAL RESEARCH.
JANT Pharmacal Corporation develops and markets medical devices, including point of care and complementary diagnostics.
Established in 1986, the company’s product portfolio includes a comprehensive line of CLIA-waived point-of-care rapid tests and instrumentation for clinical research, as well as physicians’ offices, clinics, hospitals, laboratory, wellness, and long term care settings.
Accutest® , Accustrip® and LipidPlus Brand CLIA-Waived Tests Include:
H. pylori Urease and antibody tests
Urinary Tract Infection (UTI)
Immunological fecal occult blood tests (IFOBT)
Urinalysis readers and strips
Drugs of abuse, alcohol and tobacco
LipidPlus® lipid and glucose measuring system (total cholesterol, triglycerides, glucose)
In addition, the Company is launching a CLIA-waived analyzer that includes Lipid Panels, AST, ALT, Glucose, Creatinine and general chemistry panels.
JANT also offers the physician office and reference lab a suite of clinical chemistry, hematology, immunoassay and urinalysis systems and reagents. Laboratory consultation services are available to assist the laboratory professional in maximizing laboratory efficiency and operational productivity. These services include financial feasibility assessment, work flow optimization, as well as regulatory and proficiency compliance.
YOU MIGHT ALSO BE INTERESTED IN